| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $817K | +7.5% | +788.6% |
| SG&A Expense | $1.5M | -1.7% | +268.6% |
| Operating Income | -$2.3M | -1.4% | -365.4% |
| Net Income | -$2.3M | -1.6% | -287.1% |
| EPS (Basic) | -$0.07 | +0.0% | -250.0% |
| EPS (Diluted) | -$0.07 | +0.0% | -250.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $1.6M | -42.1% | — |
| Total Assets | $2.6M | -35.1% | +2911.5% |
| Current Liabilities | $2.5M | -4.2% | -55.7% |
| Total Liabilities | $2.5M | -4.2% | -56.8% |
| Stockholders' Equity | $57K | -95.7% | +101.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | — |
| Financing Cash Flow | $187K | — | — |